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Abstract
Background: Since drug shops play an important role in treatment of fever, introducing rapid diagnostic tests
(RDTs) for malaria at drug shops may have the potential of targeting anti-malarial drugs to those with malaria
parasites and improve rational drug use. As part of a cluster randomized trial to examine impact on appropriate
treatment of malaria in drug shops in Uganda and adherence to current malaria treatment policy guidelines, a
survey was conducted to estimate baseline prevalence of, and factors associated with, appropriate treatment of
malaria to enable effective design and implementation of the cluster randomized trial.
Methods: A survey was conducted within 20 geographical clusters of drug shops from May to September 2010 in
Mukono district, central Uganda. A cluster was defined as a parish representing a cluster of drug shops. Data was
collected using two structured questionnaires: a provider questionnaire to capture data on drug shops (n=65)
including provider characteristics, knowledge on treatment of malaria, previous training received, type of drugs
stocked, reported drug sales, and record keeping practices; and a patient questionnaire to capture data from febrile
patients (n=540) exiting drug shops on presenting symptoms, the consultation process, treatment received, and
malaria diagnoses. Malaria diagnosis made by drug shop vendors were confirmed by the study team through
microscopy examination of a blood slide to ascertain whether appropriate treatment was received.
Results: Among febrile patients seen at drug shops, 35% had a positive RDT result and 27% had a positive blood
slide. Many patients (55%) had previously sought care from another drug shop prior to this consultation. Three
quarters (73%) of all febrile patients seen at drug shops received an anti-malarial, of whom 39% received an ACT
and 33% received quinine. The rest received another non-artemisinin monotherapy. Only one third (32%) of
patients with a positive blood slide had received treatment with CoartemW while 34% of those with a negative
blood slide had not received an anti-malarial. Overall appropriate treatment was 34 (95% CI: 28 – 40) with
substantial between-cluster variation, ranging from 1% to 55%.
Conclusion: In this setting, the proportion of malaria patients receiving appropriate ACT treatment at drug shops
was low. This was due to the practice of presumptive treatment, inadequate training on malaria management and
lack of knowledge that CoartemW was the recommended first-line treatment for malaria. There is urgent need for
interventions to improve treatment of malaria at these outlets.
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Background
In Uganda, malaria is highly endemic and is the leading
cause of morbidity and mortality [1,2]. The main com-
ponent of the current malaria control strategy in Uganda
is early diagnosis and effective case management. In
Uganda and elsewhere, effective treatment of fever has
been hampered by inappropriate treatment practices,
particularly in rural areas where there is poor access to
formal health facilities and self-treatment is the commonest
form of care-seeking [3-7]. Inappropriate treatment prac-
tices include, on the one hand, the continuing over-
diagnosis of malaria and over-treatment with anti-malarial
drugs among patients presenting with a fever [8-10],
constituting an unnecessary waste of resources. On the
other hand, misdiagnosis can lead to non-malaria febrile
illnesses remaining untreated, with associated risks for
the patient.
The treatment of febrile illnesses in malaria-endemic
countries has received increasing attention in the past
decade, with most countries in sub-Saharan Africa chan-
ging the first-line anti-malarial treatment to artemisinin-
based combination therapy (ACT). The higher cost of
ACT, together with increasing recognition of the import-
ance of non-malarial fevers have contributed to reconsid-
eration of existing strategies on presumptive treatment of
fevers. Accordingly, WHO has recommended targeted
treatment of malaria at all levels of health care, including
the private sector [11]. Rapid diagnostic tests (RDTs) for
malaria provide a means of confirming malaria diagnosis,
particularly in remote locations lacking electricity for
microscopes and qualified health staff. RDTs are afford-
able, quick, accurate and relatively easy to perform with
minimal training [12-15].
Although there has been a rapid increase in the roll-
out of RDTs in public health facilities, the introduction
of RDTs in the private sector has been much slower.
The private sector, in particular drug shops play an im-
portant role in provision of healthcare with up to 80% of
malaria cases treated outside the formal health sector [9].
In many cases, drug shops are frequently visited as the
first (often only) source of treatment because they are
numerous, easily accessible, and more oriented to satis-
fying consumer needs [9,10]. A recent survey in Uganda
suggests that an estimated 50% of all anti-malarial drugs
are distributed through drug shops [16]. Hence, the
introduction of RDTs in drug shops has the potential to
make a significant contribution to targeting anti-malarial
drugs to those with malaria parasites and improve rational
drug use. Although RDTs were introduced into Uganda
at lower health facilities in 2010 [17], they are not widely
implemented due to inadequate funds to avail them.
Although there is limited evidence of the best way to
scale up RDTs across sectors, there is a suggestion that
public providers do not always adhere to the test results
continuing to prescribe anti-malarial drugs to patients
with a negative RDT result [18-20]. However, supportive
interventions for provider behaviour change, particularly
supportive supervision, have been reported to be effective
in restricting anti-malarial drugs to parasite positive
patients [21-24]. There is less evidence from the private
sector and the best strategies to promote RDTs in this
sector remain unclear.
In light of the strong need for more research on im-
proving case management of malaria in the private sec-
tor, a cluster randomized trial to examine the feasibility
and cost-effectiveness of an intervention to introduce
RDTs into registered drug shops in Uganda, with a focus
on the correct use and adherence to ACT, was initiated.
The data presented here are from baseline surveys
undertaken as part of the formative research with the
objectives of determining the prevalence of appropriate
treatment for malaria and misuse of anti-malarial drugs
at baseline; to characterize patients, drug shops and pro-
viders to inform the design of the intervention; and to
explore associations between these characteristics and
treatments sold, under a situation where presumptive
diagnosis of malaria was the main practice. The results
from the qualitative component of the formative research
have previously been reported elsewhere [25,26].
Methods
Study area and population
Baseline surveys were conducted within clusters of drug
shops eligible for inclusion in an upcoming randomized
trial of RDT-based diagnosis in Mukono, Central Uganda,
a district hyperendemic for malaria, with transmission
peaks in May-June and November-December. The total
population of the district is 850,900 with an annual growth
rate of 2.3% and consists of predominantly subsistence
farmers of the Baganda ethnic group. The majority of the
population, 88%, lives in the rural areas.
A list of all 63 parishes in Mukono district was obtained
from Uganda Bureau of Statistics, and reviewed against
the inclusion criteria. Parishes were deemed eligible for
inclusion in the trial if they: i) contained a health centre
II, the lowest public health facility where early treatment
is sought; ii) contained more than 200 households to
ensure a sufficient number of patients visiting the drug
shops; and iii) contained at least one registered drug
shop registered with the District Drug Inspector (DDI).
All registered drug shops in the eligible parishes were
mapped using a global positioning system (GPS), Garmin
Corporation, and grouped into clusters. A cluster was
defined as a natural grouping of drug shops which was
often synonymous with a single parish, a geographical
demarcated area covering a population of approxi-
mately 5,000 people, but could include drug shops in a
neighbouring parish where the distance between drug
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shops in different parishes was <1 km. A total of 20
clusters fulfilled the eligibility criteria and all were in-
cluded in the study.
Prior to baseline data collection, community sensitization
activities involving village health teams were conducted
throughout the study area to raise awareness on the up-
coming cluster randomized trial in registered drug shops
and associated research activities.
Data collection
Baseline surveys were conducted via structured ques-
tionnaires with i) drug shop owners and ii) patients
exiting drug shops, in all 20 clusters between May and
September 2010. Within each cluster, drug shops owners
from all registered drug shops were invited to be in-
cluded in the survey, and written consent was obtained.
Interviews with providers captured details of the regis-
tration, provider characteristics, knowledge on treatment
of malaria, previous training received, anti-malarial drugs
stocked, drug sales, patient records kept and opening hours.
A patient exit survey was conducted, in which all patients
exiting the drug shops, who had presented with fever or a
history of fever, were invited to participate in a structured
questionnaire interview. Written informed consent from
patients was sought prior to interview. Data was captured
on the presenting illness and symptoms, treatment re-
ceived, including anti-malarial drugs purchased and how
malaria was diagnosed at the drug shops. Five social scien-
tists experienced in malaria research conducted the inter-
views. They underwent refresher training for 5 days on
qualitative research techniques, and study procedures;
and participated in the pretesting and revision of the
questionnaire tools before actual field work. Question-
naires were administered in the local language (Luganda).
Site supervisors monitored and supervised all aspects of
data collection.
Patients were also asked if they would consent to pro-
vide a finger-prick blood sample at the end of the inter-
view for confirmation of malaria parasites. Blood samples
were taken by a trained laboratory technician who pre-
pared a thick blood film for microscopy and performed
an RDT (First ResponseW). The RDT test was read in
the field and patients told the outcome. Blood smears
were stained with Giemsa and parasites were counted
against 200 leukocytes and expressed as number of par-
asites per μl of blood assuming a standard leukocyte
count of 8,000/μl of blood. A blood smear was regarded
negative after examining a minimum of 100 high power
fields with no parasites seen. Sample size calculations
indicated that a harmonic mean of 25 patients sampled
per cluster would allow estimation of the proportion of
patients receiving appropriate treatment for malaria with a
precision of ±10%, assuming an intra-cluster correlation
of 0.2 and a prevalence of 50% for the outcome of
interest [27].
Statistical methods
Data was entered and verified using Microsoft Access
2007 (Microsoft Inc., Redmond, Washington) and analysed
using STATA version 11.0 (STATA Corporation, College
Station, Texas). The proportion of correctly treated malaria
cases was based on the microscopy reading as a “gold
standard”. Appropriate treatment was defined as a com-
posite proportion including febrile patients (denomin-
ator) that are a) slide-positive and are given a first-line
anti-malarial drug; and b) slide negative patients who
do not get an anti-malarial. Socio-economic status was
measured based on reported ownership of household
assets included in national census, and a wealth index
generated through principal components analysis [28],
which was subsequently divided into quintiles.
Treatment outcomes and 95% CIs were estimated
allowing for the survey design in STATA by identifying
sampling weights and clustering of patients within drug
shop clusters. Differences between percentages were com-
pared using a t-test. Random effects logistic regression
was used to identify factors associated with appropriate
treatment at drug shops. Factors (age, sex, education level,
marital status, wealth index, treatment seeking elsewhere,
length of illness and staff characteristics) with a strong
association (odds ratio <0.5 or >1.5) with appropriate
treatment or a P-value less than 0.10 identified in uni-
variate analyses were entered into a multivariable model
using a forward stepwise selection method. Factors were
retained in this multivariable model if they remained
statistically associated at the 10% level. Models were
compared using a log-likelihood ratio test.
Ethics
Ethical approval for the research was granted from review
boards at the Uganda National Council of Science and
Technology and the London School of Hygiene and Tro-
pical Medicine. Written informed consent was sought
prior to the interviews.
Results
Interviews with treatment providers at drug shops
Characteristics of registered drug shops
There were 65 registered drug shops within the 20 clusters
eligible for inclusion in the study with a range of one to
seven shops per cluster. All drug shop owners consented
to participate in the study. Forty-six (71%) drug shops
were registered with the National Drug Authority (NDA),
the remainder with the District Drug Inspectorate (DDI).
Three drug shops (4.6%) were located in rural areas of the
district, the rest were predominately based in rural trading
centres with 13 rural (21%), and urban townships (79%).
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All drug shops were open at least five days a week, with
the majority (68%) open every day. Typically drug shop
vendors reported seeing between 2–50 febrile patients
(10 patients on average) each day, with the largest
number of patients visiting in the evening between 5-7 pm.
Staff characteristics and training
The majority (80%) of drug shop staff were female and
educated to secondary level (97%). Although many drug
shop operators (68%) were qualified health workers; less
than half (46%) had received any training on management
of malaria in the last 5 years, such as ACT or Integrated
Management of Childhood Illness (IMCI) guidelines; none
had training in microscopy and only 5% had been trained
on RDTs (Table 1). When their knowledge on the current
malaria treatment policy and RDTs was assessed, 42 (65%)
drug shop staff claimed that they knew the recommended
first-line anti-malarial treatment, but only 43% (28/65)
specified an ACT, such as CoartemW; whilst 11 could not
specify any drug. Of the 42 claiming knowledge of the
treatment policy, 15 (36%) reported they had learned
about the first-line treatment from the national guidelines;
11 (26%) from another health worker; five (12%) from
training workshops; while the remainder stated that they
had learned about the first-line treatment from the DDI,
the radio or general conversation. Regarding RDTs, only
19 of the 65 drug shop operators interviewed (29%) knew
what an RDT was for; of whom 10 had learned about
RDTs from another health worker; 6 from the national
guidelines; while 3 had heard about RDTs from the re-
search team as part of community sensitization/consent
process. Only four drug shops (6%) had a copy of the first-
line malaria treatment policy; two drug shops (3%) had
additional posters and leaflets available on ACT, and only
one had any information/material available on RDTs for
customers.
Diagnosis and treatment of malaria at drug shops
Thermometers were available in the majority of shops
(58/65, 89%), while only four (6%) had a functioning
microscope and offered malaria testing. Three quarters
(75%) of shops stocked CoartemW, the recommended
first-line treatment for malaria in Uganda. Other anti-
malarial drugs stocked included quinine (89%), FansidarW
(89%), CamoquineW (54%) and chloroquine (38%). None
of the drug shops stocked artemisinin monotherapies.
When drug shop vendors were asked what treatment
they prescribe to a febrile child, the most frequently
reported anti-malarial prescribed was quinine (44%), often
in conjunction with another medication, such as Fansidar,
paracetamol tablets and syrup. Only 40% said they would
prescribe CoartemW, again often given in combination with
paracetamol or an antibiotic; 8% did not prescribe any
anti-malarial, instead they prescribed paracetamol and/
or antibiotics. A similar prescribing pattern was reported
for adults (Figure 1). Over four-fifths (53/64, 83%) of drug
shops reported seeing patients with severe illness; with
an average of two patients with severe illness seen per
week. All but one drug shop vendor reported referring
patients with severe illness; 32 (62%) referred to a health
centre, 17 (33%) to a hospital. Although two-fifths (38%)
of drug shop vendors stated that they did not encounter
any constraints in referring patients, the majority did
report constraints to referral. Lack of money was iden-
tified by drug shop vendors as the biggest hindrance to
referral (Table 2).
Exit interviews with patients at drug shops
Exit interviews were conducted with a total of 540 clients
seeking treatment for fever; none of those approached
refused to participate in the exit interview. The number
Table 1 Characteristics of staff in registered drug shops
Staff characteristics (N=65) N (%)
Sex
Male 13 (20%)
Female 52 (80%)
Education
Primary 0 (0%)
Secondary 63 (97%)
Tertiary (Technical/University) 2 (3%)
Professional training
High Level of Training 30 (46%)
Enrolled Nurse 20
Midwife 5
Clinical Officer 3
Comprehensive nurse 1
Psychiatric nurse 1
Low Level of Training 35 (54%)
Nursing Aide 21
Auxiliary Nurse 14
Knowledge of first line malaria treatment
No 37 (57%)
Yes 28 (43%)
Training in malaria case management ‡
Artemisinin Combination Therapy (ACT) 18 (28%)
IMCI Guidelines§ 12 (18%)
Rapid diagnostic tests (RDTs) 3 (5%)
Microscopy 0 (0%)
None of the above training 39 (60%)
Knowledge of RDT
Does not know 46 (71%)
Knows 19 (29%)
Notes:
‡ more than one type of training possible.
§ IMCI stands for Integrated Management of Childhood Illness [29].
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of patients interviewed per drug shop ranged between
five to 68 patients; and all patients’ (or their caregivers)
present at the drug shop consented to provide a blood
slide (n=540) (data not shown). The characteristics of
the patients interviewed are presented in Table 3. Patients’
age ranged from 1 month to 76 years; 35% were under
the age of 5 years. In the majority of cases, the patients
who were sick came to the drug shop in person, and
only 5% of patients were seeking treatment for someone
else. When asked about symptoms, two-fifths (41%) of
patients interviewed also reported a cough alongside the
fever; other co-presenting symptoms included common
cold (34%), headache (19%), abdominal pain (14%) and
diarrhoea (10%) (Table 3).
In over half of the exit interviews, patients reported
that they chose this particular drug shop for treatment
because they had been there before (61%) and because
the provider was friendly (54%). Other reasons given in-
cluded proximity of the drug shop to their home (38%),
because the provider was qualified (26%), ability to get
treatment on credit (25%) and availability of drugs (23%).
The median number of days from the start of illness to the
time of visiting a drug shop was 3 days; and just under
half (48%) had sought treatment elsewhere before visit-
ing the drug shop where they were interviewed. The
most popular source of previous treatment was another
drug shop (Figure 2).
Prevalence of malaria and appropriate treatment
Of the 494 patients (91%) who were told the name of
their illness by the drug shop vendor, three quarters
(387/494) reported having been told they had malaria.
However, results from the examination by the research
team of blood samples provided after the exit interviews
showed that only 190 (35%) of the 538 (2 results missing)
had a positive RDT while 145/540 (27%), had a positive
blood slide. About three quarters (73%) of patients re-
ceived an anti-malarial, of which 39% received an ACT,
33% received quinine, and the rest another non-artemisinin
monotherapy. In shops which did not have any ACT in
stock, quinine was the most commonly prescribed anti-
malarial (Table 4). Of even greater concern was the find-
ing that in shops that did stock ACT, almost a third of
the patients that were later found to be blood-slide
positive (40/128, 31%) had not received an ACT. Among
patients interviewed and found to have a positive blood
slide by microscopy, 32% (95% CI: 20-45%) had received
treatment with CoartemW from the drug shop, but 17%
(95% CI: 10–23) received no anti-malarial at all. Among
those with a negative blood slide, a third (95% CI: 27-42%)
had not received an anti-malarial but 66% (95% CI:
58-73%) had needlessly received an anti-malarial. Overall,
appropriate treatment by drug shop vendors in the
absence of RDT testing was estimated at 34% (95% CI
28 – 40%) with substantial between-cluster variation,
ranging from 1% to 55%. Treatment with antibiotics
was similar among those with and without confirmed
malaria and in drug shops with and without ACT in
stock (Table 4).
In univariable analysis, patients who had a higher wealth
index (P=0.03) and increasing duration of illness (P=0.03)
were more likely to be treated appropriately. There was no
Figure 1 Treatment prescribed to adults and children who present with fever by registered drug shop staff.
Table 2 Constraints reported by drug shop staff when
referring patients
Perceived constraint (N=65) N (%)
No perceived constraints 25 (38%)
One or more constraints reported* 40 (62%)
Patients do not have the money 30
Patients do not comply (reasons unknown) 22
No drugs at the referral facility 15
Referral facilities are too far 11
Waiting time at health centre 2
No stamps on referral letters 1
Patient doubt your advice 1
Severe symptoms 1
* More than one response possible.
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evidence that factors such as training on malaria and staff
training were associated with appropriate treatment. In
multivariable analysis, patient’s household wealth, length
of a patient’s illness remained independently associated
with receiving appropriate treatment (Table 5).
Discussion
The present results show that appropriate treatment for
malaria provided in drug shops is low; with a third of
patients receiving appropriate treatment, as defined by
microscopy examination of a blood sample taken at exit.
At the same time, the proportion of non-parasitaemic
patients who receive unnecessary anti-malarial drugs is
high. The factors attributed to this scenario are that
diagnosis of malaria in drug shops was primarily pre-
sumptive (without laboratory confirmation); few drug
shop staff had received training on management of
malaria; few knew that CoartemW was the first-line anti-
malarial drug; few shops had adequate guidelines on
management of malaria; few knew what an RDT was
used for; and there was little supervision. The conse-
quences of inappropriate treatment were evident in the
fact that many patients in the exit survey had previously
sought treatment at another drug shop. In addition to
the public health concern of increasing severity of symp-
toms due to ineffective or inadequate treatment, the
economic burden to households of repeated treatment
seeking cannot be overlooked. The findings in the present
study emphasize the need for implementing interventions
aimed at improving appropriate treatment of malaria in
drug shops.
The present findings are consistent with another recent
study in Uganda that has shown that few (10.3%) febrile
children treated at drug shops received appropriate treat-
ment for malaria, and also that few children with both
cough and fast breathing received amoxicillin. Similarly,
few children with diarrhea received oral rehydration salts,
and none received zinc tablets. The study concluded that
management of common childhood illness at private
sector drug shops in rural Uganda was largely inappro-
priate [30].
A recent study in Cameroon found that 45% of patients
at medicine retailers received ACT, 29% were confirmed
Table 3 Characteristics of febrile patients exiting
registered drug shops
Patient characteristics Frequency
Age (years), N=540
<5 190 (35%)
5-14 120 (22%)
≥15 230 (43%)
Sex, N=540
Male 248 (46%)
Female 292 (54%)
Pregnant†, N=127
Yes 9 (7%)
No 118 (93%)
Education (or caregiver education)‡, N=353
None 45 (13%)
Primary 196 (55%)
Secondary 99 (28%)
Tertiary (Technical/University) 13 (4%)
Marital status§ n=533
Single 375 (71%)
Married/Cohabiting 129 (24%)
Widowed/Separated 29 (5%)
Wealth index* n=539
Poorest 210 (39%)
Less poor 164 (30%)
Least poor 165 (31%)
Presenting symptoms#
Cough 224 (41%)
Common cold 184 (34%)
Headache 100 (19%)
Abdominal pain 74 (14%)
Diarrhoea 56 (10%)
Notes:
† Only asked among females aged 15 years and over (n=127).
‡ Not all customers interpreted the question as the education of the patient or
caregiver if the patient is a child. Hence results on available for 353 patients.
§ Marital status is not known for 7 patients.
*Wealth index was not known for 1 patient. Variables included in the
calculation of the wealth index were household occupation, housing type,
ownership of radio, bicycle, boda boda (motorbike), car, shop.
# Patients may have presented with more than one symptom.
0.8%
55%
24%
4%
11%
6%
Drug Shop Public health unit 
Public hospital Private clinic 
Traditional healer Other
Figure 2 Sources of previous treatment before visiting the
drug shop.
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Table 4 Treatment by diagnosis results and drug availability
Availability of ACT Microscopy (blood slide result)
Treatment received No of patients % (95% CI) ACT in stock % (95% CI) ACT not in stock % (95% CI) p-value Positive % (95% CI) Negative% % (95% CI) p-value
Coartem (ACT) 154 27 (19–35) 154 100 0 n/a 53 32 (20 – 45) 101 26 (17 – 34) 0.29
Quinine 131 26 (18 – 33) 73 19 (16 – 22) 58 52 (38 – 66) <0.01 46 36 (26 – 47) 85 22 (15 – 29) <0.01
Fansidar 71 11 (5 – 17) 51 11 (5 – 17) 20 12 (0.1 – 24) 0.84 16 11 (5–19) 55 9 (4 – 14) 0.17
Camoquine 27 5 (2 – 8) 18 5 (1 – 8) 9 6 (3 – 8) 0.61 6 4 (2–6) 21 5 (0.1 – 9) 0.73
Chloroquine 14 2 (0.1 – 4) 12 2 (0.3 – 4) 2 1 (−1 – 3) 0.44 4 2 (−0.2 – 4) 10 2 (0.4 – 3.6) 0.95
No anti-malarial 148 30 (23 – 37) 305 74 (70 – 78) 87 68 (60 – 76) 0.20 123 83 (77 – 90) 269 66 (58 – 73) <0.01
Antibiotic 151 31 (22 – 40) 105 29 (18 – 39) 46 40 (35 – 46) 0.03 43 33 (14 – 53) 108 30 (24 – 36) 0.68
Paracetamol 385 69 (61 – 76) 293 68 (60 – 78) 92 70 (61 – 77) 0.93 115 78 (64 – 92) 270 65 (59 – 72) 0.03
Appropriate treatment.
34 (28 – 40).
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with malaria while 70% negative patients received an anti-
malarial drug and also concluded that there was inappro-
priate treatment of malaria at these outlets [31]. Another
study in Nigeria reported that ACT were available in
44.7% of private facilities, but that few used ACT for the
treatment of malaria, more frequently using SP, chloro-
quine and artemisinin monotherapy drugs [32].
The findings of the present study suggest that pri-
vate providers, especially the lower cadre staff, may be
overlooked in training them on treatment guidelines
Table 5 Factors associated with access to appropriate treatment at drug shops
Univariable analysis Multivariable analysis
Patient characteristics n OR (95% CI) p-value OR (95% CI) p-value
Sex
Male 248 1 0.84
Female 292 0.96 (0.67, 1.39)
Age (years)
<5 190 1 0.44
5-14 120 1.37 (0.84, 2.25)
≥ 15 230 1.17 (0.77, 1.79)
Education (or caregiver education)
None 45 1 0.34
Primary 196 1.65 (0.78, 3.51)
Secondary 99 1.90 (0.84, 4.27)
Tertiary (Technical/University) 13 0.84 (0.19, 2.73)
Marital status
Single 375 1 0.32
Married/Cohabiting 129 0.81 (0.52, 1.26)
Widowed/Separated 29 1.52 (0.69, 3.34)
Wealth index
Poorest 210 1 0.03 1 0.03
Less poor 164 0.59 (0.37, 0.93) 0.62 (0.38 – 0.99
Least poor 165 1.08 (0.70, 1.67) 1.13 (0.72 – 1.75)
Previously sought treatment elsewhere
No 283 1 0.27
Yes 257 1.23 (0.85, 1.78)
Length of illness (hours/days)
≤24 hours 56 1 0.03 1 0.04
24-48 hours 133 1.78 (0.85, 3.72) 1.73 (0.82 – 3.63)
3 – 7 days 299 1.61 (0.81, 3.21) 1.51 (0.76 – 3.02)
> 7 days 52 3.49 (1.49, 8.16) 3.25 (1.38 -7.66)
Health worker characteristics
Staff sex
Male 13 1
Female 52 0.83 (0.50, 1.37) 0.46
Staff Training
High level of training 30 1
Low level of training 35 0.85 (0.57, 1.26) 0.41
Knowledge first line treatment is ACT
No 37 1
Yes 28 1.08 (0.73, 1.60) 0.70
Attended training on malaria
No 39 1
Yes 26 1.04 (0.68, 1.60) 0.84
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and/or other professional development. In many coun-
tries, private providers are an integral component of the
malaria control strategy to increase access to prompt
effective treatment [33]. However, for this strategy to
be fully effective the professional knowledge of private
providers should be up-to-date and their practice
should be in line with national policy. It has recently
been shown that availability of ACT the private sector
in Uganda is now over 65% [34], but the findings illus-
trate how the goal of access to prompt and effective
treatment cannot be achieved without training drug
shops on the use RDTs to guide treatment and updating
their knowledge on appropriate management of malaria.
These two measures could tremendously improve man-
agement of malaria, especially in rural areas where micros-
copy is non-existent.
This study documents the wide use of anti-malarial
drugs among patients with fever at drug shops (Table 4)
especially quinine yet this is not a first-line anti-malarial
drug. The continued use of non-ACT drugs is a concern
for the patient who may be receiving an ineffective treat-
ment, but may also have implications on drug resistance,
especially for SP, the recommended drug for malaria
prevention in pregnancy (IPTp). There is pressing need
to educate the drug shops about the necessity of appro-
priate treatment of malaria according to national policy.
It is further recommended that the National Dug Authority
and the District Drug Inspector should intensify supervi-
sion of drug shops on this aspect.
Previous studies have also documented anti-malarial
drug over-use at drug shops and recommendations to
improve targeting malaria patients and rational drug use
have been made [35-37]. The findings that most patients
came to the drug shop in person, indicates that diagnos-
tic testing of a patient blood sample should be possible
in the majority of cases. Recent studies in Uganda have
found that drug shops have a desire to stock RDTs and
use them to guide treatment; and that most of them
can store, administer and dispose of RDTs properly and
charge mark-ups similar to those charged on common
medicines [38].
In conclusion, the proportion of malaria patients re-
ceiving appropriate treatment at registered drug shops in
Uganda is unacceptably low. This is due to a combination
of presumptive diagnosis of malaria without laboratory
confirmation; inadequate training on malaria management
and inadequate knowledge that CoartemW is the first-line
anti-malarial drug.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AKM, SC, KSH and PM conceived the study. All authors participated in the
design and implementation of data collection activities, SL and BC
undertook the data analysis. AKM wrote the first draft of the manuscript and
all authors contributed to, read and approved the final manuscript.
Acknowledgments
We are grateful to the drug shop operators and patients in Mukono district
who consented to give their time to be interviewed, and to Charity Wamala,
Deborah Namisango, Steven Kalake and Anthony Kadoma who carried out the
surveys. This research is supported by the ACT Consortium, which is funded
through a grant from the Bill & Melinda Gates Foundation to the London
School of Hygiene and Tropical Medicine. Sian Clarke is supported by the
Wellcome Trust through a Research Career Development Fellowship (084933).
Author details
1School of Public Health, Makerere University and Commissioner Health
Services, Ministry of Health, Box 7272, Kampala, Uganda. 2Department of
Disease Control, London School of Hygiene and Tropical Medicine, Keppel
Street, London WC1E 7HT, UK. 3Department of Infectious Disease
Epidemiology, London School of Hygiene and Tropical Medicine, Keppel
Street, London WC1E 7HT, UK. 4Department of Global Health and
Development, London School of Hygiene and Tropical Medicine, 15-17
Tavistock Place, London WC1H 9SH, UK. 5Centre for Medical Parasitology,
University of Copenhagen, Copenhagen, Denmark.
Received: 24 August 2012 Accepted: 6 April 2013
Published: 16 April 2013
References
1. Ministry of Health: Health Sector Strategic Plan III. Box 7272, Kampala,
Uganda: Ministry of Health; 2010.
2. Omumbo JA, Snow RW: Plasmodium falciparum parasite prevalence in
East Africa: a review. East Afr Med J 2004, 81:649–656.
3. Abuya TO, Mutemi W, Karisa B, Ochola SA, Fegan G, Marsh V: Use of
over-the-counter malaria medicines in children and adults in three
districts in Kenya: implications for private medicine retail interventions.
Malar J 2007, 6:57.
4. Kindermans JM, Vandenbergh D, Vreeke E, Olliaro P, D’Altilia JP: Estimating
antimalarial drug consumption in Africa before the switch to
artemisinin-based combination therapies (ACTs). Malar J 2007, 6:9.
5. Mbonye AK, Bygbjerg IC, Magnussen P: Prevention and treatment
practices and implications for malaria control in Mukono District
Uganda. J Biosoc Sci 2008, 40:283–296.
6. van der Geest S: Self-care and the informal sale of drugs in South
Cameroon. Soc Sci Med 1987, 25:293–305.
7. Ndyomugyenyi R, Neema S, Magnussen P: The use of formal and informal
services for antenatal care and malaria treatment in rural Uganda.
Health Policy Plan 1998, 13:94–102.
8. Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungule E, Mwerinde O,
Saganda K, Shao J, Kitua A, Olomi R, Greenwood BM, Whitty CJ: Over-diagnosis
of malaria in patients with severe febrile illness in Tanzania: a prospective
study. BMJ 2004, 20:1212.
9. Nankabirwa J, Zurovac D, Njogu JN, Rwakimari JB, Counihan H, Snow RW,
Tibenderana JK: Malaria misdiagnosis in Uganda--implications for policy
change. Malar J 2009, 8:66–66.
10. Ndyomugyenyi R, Magnussen P, Clarke S: Diagnosis and treatment of
malaria in peripheral health facilities in Uganda: findings from an area of
low transmission in South-Western Uganda. Malar J 2007, 6:39.
11. World Health Organization: Guidelines for the Treatment of Malaria.
Secondth edition. Geneva: World Health Organization; 2010.
12. D’Acremont V: Massive reduction of antimalarial prescription after Rapid
Diagnostic Test implementation in Dar es Salaam. Nairobi, Kenya: Tanzania.
Presented at MIM Pan-African Malaria Conference; 2009.
13. Barnish G, Bates I, Iboro J: Newer drug combinations for malaria may be
impractical unless diagnostic accuracy can be improved. BMJ 2004,
328:1511–1512.
14. Amexo M, Tolhurst R, Barnish G, Bates I: Malaria misdiagnosis: effects on
the poor and vulnerable. Lancet 2004, 364:1896–1898.
15. Reyburn H, Mbakilwa H, Mwangi R, Mwerinde O, Olomi R, Drakeley C,
Whitty CJ: Rapid diagnostic tests compared with malaria microscopy for
guiding outpatient febrile illness in Tanzania: randomised trial. BMJ 2007,
334:403–409.
Mbonye et al. Malaria Journal 2013, 12:131 Page 9 of 10
http://www.malariajournal.com/content/12/1/131
16. O’Connell KA, Gatakaa H, Poyer S, Njogu J, Evance I, Munroe E, Solomon T,
Goodman C, Hanson K, Zinsou C, Akulayi L, Raharinjatovo J, Arogundade E,
Buyungo P, Mpasela F, Adjibabi CB, Agbango JA, Ramarosandratana BF,
Coker B, Rubahika D, Hamainza B, Chapman S, Shewchuk T, Chavasse D:
Got ACTs? Availability, price, market share and provider knowledge of
anti-malarial medicines in public and private sector outlets in six
malaria-endemic countries. Malar J 2011, 10:326.
17. Ministry of Health: Malaria Control Strategy. Box 7272, Kampala, Uganda:
Ministry of Health; 2010.
18. Hamer DH, Ndhlovu M, Zurovac D, Fox M, Yeboah-Antwi K, Chanda P,
Sipilinyambe N, Simon JL, Snow RW: Improved diagnostic testing and
malaria treatment practices in Zambia. JAMA 2007, 297:2227–2231.
19. Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, Mwerinde O,
Saganda K, Shao J, Kitua A, Olomi R, Greenwood BM, Whitty CJ:
Overdiagnosis of malaria in patients with severe febrile illness in
Tanzania: a prospective study. BMJ 2004, 329:1212.
20. Ansah EK, Narh-Bana S, Epokor M, Akanpigbiam S, Quartey AA, Gyapong J,
Whitty CJ: Rapid testing for malaria in settings where microscopy is
available and peripheral clinics where only presumptive treatment is
available: a randomised controlled trial in Ghana. BMJ 2010, 340:c930.
21. D’Acremont V, Lengeler C, Mshinda H, Mtasiwa D, Tanner M, Genton B:
Time to move from presumptive malaria treatment to laboratory-confirmed
diagnosis and treatment in African children with fever. PLoS Med 2009,
6:e252.
22. Hopkins H: Effectiveness and safety of training in fever case management and
RDT use at health centres in Uganda. New Orleans: Presented at American
Society of Tropical Medicine & Hygiene 57th Annual Meeting; 2008.
23. Kyabayinze DJ, Asiimwe C, Nakanjako D, Nabakooza J, Counihan H,
Tibenderana JK: Use of RDTs to improve malaria diagnosis and fever case
management at primary health care facilities in Uganda. Malar J 2010,
9:200.
24. Msellem MI, Martensson A, Rotllant G, Bhattarai A, Stromberg J, Kahigwa E,
Garcia M, Petzold M, Olumese P, Ali A, Björkman A: Influence of rapid
malaria diagnostic tests on treatment and health outcome in fever
patients. Zanzibar: a crossover validation study. PLoS Med 2009, 6:e1000070.
25. Mbonye AK, Ndyomugyenyi R, Turinde A, Magnussen P, Clarke S, Chandler
C: The feasibility of introducing rapid diagnostic tests for malaria in drug
shops in Uganda. Malar J 2010, 9:367.
26. Chandler CI, Hall-Clifford R, Asaph T, Pascal M, Clarke S, Mbonye AK:
Introducing malaria rapid diagnostic tests at registered drug shops in
Uganda: limitations of diagnostic testing in the reality of diagnosis.
Soc Sci Med 2011, 72:937–944.
27. Bennett S, Woods T, Liyanage WM, Smith DL: A simplified general method
for cluster-sample surveys of health in developing countries. World Health
Stat Q 1991, 44:98–106.
28. Filmer D, Pritchett LH: Estimating wealth effects without expenditure
data—or tears: An application to educational enrollments in states of
India. Demography 2001, 38:115–132.
29. World Health Organization: Technical updates of the guidelines on the
Integrated Management of Childhood Illness (IMCI): evidence and
recommendations for further adaptations. Switzerland: World Health
Organization; 2008.
30. Awor P, Wamani H, Bwire G, Jagoe G, Peterson S: Private sector drug
shops in integrated community case management of malaria,
pneumonia, and diarrhea in children in Uganda. AmJTrop Med Hyg 2012,
87:92–96.
31. Mangham LJ, Cundill B, Achonfuh O, Ambebila JN, Lele AK, Orang-Ojong B,
Pamen-Ngako J, Wiseman V, Mbacham WF: Malaria prevalence and
treatment of febrile patients at health facilities and medicine retailers in
Cameroon. Trop Med Int Health 2012, 17:330–342.
32. Uzochukwu BC, Chiegboka LO, Enwereuzo C, Nwosu U, Okorafor D,
Onwujekwe OE, Uguru NP, Sibeudu FT, Ezeoke OP: Examining appropriate
diagnosis and treatment of malaria: availability and use of rapid
diagnostic tests and artemisinin-based combination therapy in public
and private health facilities in south east Nigeria. BMC Publ Health 2010,
10:486.
33. Chiguzo AN, Mugo RW, Wacira DG, Mwenda JM, Njuguna EW: Delivering
new malaria drugs through grassroots private sector. East Afr Med J 2008,
9:425–431.
34. Tougher S, the ACTwatch Group, Ye Y, Amuasi JH, Kourgueni IA, Thomson
R, Goodman C, Mann AG, Ren R, Willey BA, Adegoke CA, Amin A, Ansong D,
Bruxvoort K, Diallo DA, Diap G, Festo C, Johanes B, Juma E, Kalolella A,
Malam O, Mberu B, Ndiaye S, Nguah SB, Seydou M, Taylor M, Rueda ST,
Wamukoya M, Arnold F, Hanson K: Effect of the Affordable Medicines
Facility—malaria (AMFm) on the availability, price, and market share of
quality-assured-artemisinin-based combination therapies in seven
countries: a before-and-after analysis of outlet survey data. Lancet 2012,
380:1916–1926.
35. Kamya MR, Bakyayita NN, Talisuna AO, Were WM, Staedke SG: Increasing
drug resistance in Uganda and revision of the national drug policy.
Trop Med Int Health 2002, 7:1031–1041.
36. Kachur SP, Khatib RA, Kaizer E, Fox SS, Abdulla SM, Bloland PB: Prevalence
of malaria parasitaemia among clients seeking treatment for fever or
malaria at drug stores in rural Tanzania 2004. Trop Med Int Health 2006,
11:441–451.
37. Ndyomugyenyi R, Magnussen P, Clarke S: Malaria treatment-seeking
behaviour and drug prescription practices in an area of low transmission
in Uganda: implications for prevention and control. Trans R Soc Trop Med
Hyg 2007, 101:209–15.
38. Cohen J, Fink G, Berg K, Aber F, Jordan M, Maloney K, Dickens W: Feasibility
of distributing rapid diagnostic tests for malaria in the retail sector: evidence
from an implementation study in Uganda. PLoS One 2012, 7:e48296.
doi:10.1186/1475-2875-12-131
Cite this article as: Mbonye et al.: Treatment of fevers prior to
introducing rapid diagnostic tests for malaria in registered drug shops
in Uganda. Malaria Journal 2013 12:131.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Mbonye et al. Malaria Journal 2013, 12:131 Page 10 of 10
http://www.malariajournal.com/content/12/1/131
